Publications 2016

  1. Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain.
    Lope V, Fernández de Larrea N, Pérez-Gómez B, Martín V, Moreno V, Costas L, Longo F, Jiménez-Moleón JJ, Llorca J, Ascunce N, Peiró-Pérez R, Altzibar JM, Tardón A, Alguacil J, Navarro C, Sierra Á, Vega AB, Villafañe A, Castaño-Vinyals G, Kogevinas M, Pollán M, Aragonés N. PLoS One. 2016;11(10):e0164620. doi: 10.1371/journal.pone.0164620. Epub: 2016 Oct 24. PMID: 27776142; PMCID: PMC5077095
  2. Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain.
    Rosato V, Tavani A, Gracia-Lavedan E, Guinó E, Castaño-Vinyals G, Villanueva CM, Kogevinas M, Polesel J, Serraino D, Pisa FE, Barbone F, Moreno V, La Vecchia C, Bosetti C. Front Oncol. 2016;6():210. doi: 10.3389/fonc.2016.00210. Epub: 2016 Oct 6. PMID: 27766252; PMCID: PMC5052265
  3. Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.
    Ibáñez-Sanz G, Garcia M, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Domènech X, Vidal C, Soriano A, Moreno V, 'Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study' Working Group. Dig Liver Dis. 2016 Oct;48(10):1249-54. doi: 10.1016/j.dld.2016.06.011. Epub: 2016 Jun 21. PMID: 27378703
  4. Downregulation of the Deiminase PADI2 Is an Early Event in Colorectal Carcinogenesis and Indicates Poor Prognosis.
    Cantariño N, Musulén E, Valero V, Peinado MA, Perucho M, Moreno V, Forcales SV, Douet J, Buschbeck M. Mol Cancer Res. 2016 Sep;14(9):841-8. doi: 10.1158/1541-7786.MCR-16-0034. Epub: 2016 Jun 8. PMID: 27280713
  5. Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study.
    Dierssen-Sotos T, Gómez-Acebo I, de Pedro M, Pérez-Gómez B, Servitja S, Moreno V, Amiano P, Fernandez-Villa T, Barricarte A, Tardon A, Diaz-Santos M, Peiro-Perez R, Marcos-Gragera R, Lope V, Gracia-Lavedan E, Alonso MH, Michelena-Echeveste MJ, Garcia-Palomo A, Guevara M, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Llorca J. BMC Cancer. 2016 Aug 20;16(1):660. doi: 10.1186/s12885-016-2692-4. Epub: 2016 Aug 20. PMID: 27542890; PMCID: PMC4992258
  6. The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.
    Gómez-Acebo I, Dierssen-Sotos T, Palazuelos C, Pérez-Gómez B, Lope V, Tusquets I, Alonso MH, Moreno V, Amiano P, Molina de la Torre AJ, Barricarte A, Tardon A, Camacho A, Peiro-Perez R, Marcos-Gragera R, Muñoz M, Michelena-Echeveste MJ, Ortega Valin L, Guevara M, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Llorca J. PLoS One. 2016;11(8):e0159672. doi: 10.1371/journal.pone.0159672. Epub: 2016 Aug 10. PMID: 27508297; PMCID: PMC4979888
  7. Night shift work and stomach cancer risk in the MCC-Spain study.
    Gyarmati G, Turner MC, Castaño-Vinyals G, Espinosa A, Papantoniou K, Alguacil J, Costas L, Pérez-Gómez B, Martin Sanchez V, Ardanaz E, Moreno V, Gómez-Acebo I, Fernández-Tardon G, Villanueva Ballester V, Capelo R, Chirlaque MD, Santibáñez M, Pollán M, Aragonés N, Kogevinas M. Occup Environ Med. 2016 Aug;73(8):520-7. doi: 10.1136/oemed-2016-103597. Epub: 2016 Jun 16. PMID: 27312400
  8. Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients.
    Kehlet SN, Sanz-Pamplona R, Brix S, Leeming DJ, Karsdal MA, Moreno V. Sci Rep. 2016 Jul 28;6():30599. doi: 10.1038/srep30599. Epub: 2016 Jul 28. PMID: 27465284; PMCID: PMC4964349
  9. Colorectal cancer risk and nitrate exposure through drinking water and diet.
    Espejo-Herrera N, Gràcia-Lavedan E, Boldo E, Aragonés N, Pérez-Gómez B, Pollán M, Molina AJ, Fernández T, Martín V, La Vecchia C, Bosetti C, Tavani A, Polesel J, Serraino D, Gómez Acebo I, Altzibar JM, Ardanaz E, Burgui R, Pisa F, Fernández-Tardón G, Tardón A, Peiró R, Navarro C, Castaño-Vinyals G, Moreno V, Righi E, Aggazzotti G, Basagaña X, Nieuwenhuijsen M, Kogevinas M, Villanueva CM. Int J Cancer. 2016 Jul 15;139(2):334-46. doi: 10.1002/ijc.30083. Epub: 2016 Apr 4. PMID: 26954527
  10. Algorithmic methods to infer the evolutionary trajectories in cancer progression.
    Caravagna G, Graudenzi A, Ramazzotti D, Sanz-Pamplona R, De Sano L, Mauri G, Moreno V, Antoniotti M, Mishra B. Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):E4025-34. doi: 10.1073/pnas.1520213113. Epub: 2016 Jun 28. PMID: 27357673; PMCID: PMC4948322
  11. Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.
    Zeng C, Matsuda K, Jia WH, Chang J, Kweon SS, Xiang YB, Shin A, Jee SH, Kim DH, Zhang B, Cai Q, Guo X, Long J, Wang N, Courtney R, Pan ZZ, Wu C, Takahashi A, Shin MH, Matsuo K, Matsuda F, Gao YT, Oh JH, Kim S, Jung KJ, Ahn YO, Ren Z, Li HL, Wu J, Shi J, Wen W, Yang G, Li B, Ji BT, Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Brenner H, Schoen RE, Küry S, Colorectal Transdisciplinary (CORECT) Study, Gruber SB, Schumacher FR, Stenzel SL, Colon Cancer Family Registry (CCFR), Casey G, Hopper JL, Jenkins MA, Kim HR, Jeong JY, Park JW, Tajima K, Cho SH, Kubo M, Shu XO, Lin D, Zeng YX, Zheng W. Gastroenterology. 2016 Jun;150(7):1633-1645. doi: 10.1053/j.gastro.2016.02.076. Epub: 2016 Mar 8. PMID: 26965516; PMCID: PMC4909543
  12. Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies.
    Azuara D, Santos C, Lopez-Doriga A, Grasselli J, Nadal M, Sanjuan X, Marin F, Vidal J, Montal R, Moreno V, Bellosillo B, Argiles G, Elez E, Dienstmann R, Montagut C, Tabernero J, Capellá G, Salazar R. Mol Cancer Ther. 2016 May;15(5):1106-12. doi: 10.1158/1535-7163.MCT-15-0820. Epub: 2016 Apr 1. PMID: 27037411
  13. Endoscopic band ligation without resection in selected patients for small and superficial upper gastrointestinal tract lesions.
    Ibáñez-Sanz G, Gornals JB, Rivas L, Salord S, Paúles MJ, Botargues JM, Galán M. Rev Esp Enferm Dig. 2016 May;108(5):250-6. doi: 10.17235/reed.2016.4031/2015. PMID: 27022723
  14. Mutanome and expression of immune response genes in microsatellite stable colon cancer.
    Sanz-Pamplona R, Gil-Hoyos R, López-Doriga A, Alonso MH, Aussó S, Molleví DG, Santos C, Sanjuán X, Salazar R, Alemany R, Moreno V. Oncotarget. 2016 Apr 5;7(14):17711-25. doi: 10.18632/oncotarget.7293. PMID: 26871478; PMCID: PMC4951244
  15. Mutations in JMJD1C are involved in Rett syndrome and intellectual disability.
    Sáez MA, Fernández-Rodríguez J, Moutinho C, Sanchez-Mut JV, Gomez A, Vidal E, Petazzi P, Szczesna K, Lopez-Serra P, Lucariello M, Lorden P, Delgado-Morales R, de la Caridad OJ, Huertas D, Gelpí JL, Orozco M, López-Doriga A, Milà M, Perez-Jurado LA, Pineda M, Armstrong J, Lázaro C, Esteller M. Genet Med. 2016 Apr;18(4):378-85. doi: 10.1038/gim.2015.100. Epub: 2015 Jul 16. PMID: 26181491; PMCID: PMC4823641
  16. Association of Streptococcus gallolyticus subspecies gallolyticus with colorectal cancer: Serological evidence.
    Butt J, Romero-Hernández B, Pérez-Gómez B, Willhauck-Fleckenstein M, Holzinger D, Martin V, Moreno V, Linares C, Dierssen-Sotos T, Barricarte A, Tardón A, Altzibar JM, Moreno-Osset E, Franco F, Requena RO, Huerta JM, Michel A, Waterboer T, Castaño-Vinyals G, Kogevinas M, Pollán M, Boleij A, de Sanjosé S, Del Campo R, Tjalsma H, Aragonés N, Pawlita M. Int J Cancer. 2016 Apr 1;138(7):1670-9. doi: 10.1002/ijc.29914. Epub: 2015 Nov 20. PMID: 26537841
  17. Spontaneous intramural esophageal dissection: an unusual onset of eosinophilic esophagitis.
    Ibáñez-Sanz G, Rodríguez-Alonso L, Romero NM. Rev Esp Enferm Dig. 2016 Mar;108(3):156-7. doi: . PMID: 26949147
  18. Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposis.
    Mur P, Sánchez-Cuartielles E, Aussó S, Aiza G, Valdés-Mas R, Pineda M, Navarro M, Brunet J, Urioste M, Lázaro C, Moreno V, Capellá G, Puente XS, Valle L. Sci Rep. 2016 Feb 8;6():20697. doi: 10.1038/srep20697. Epub: 2016 Feb 8. PMID: 26852919; PMCID: PMC4745060
  19. Perinatal and childhood factors and risk of breast cancer subtypes in adulthood.
    Lope V, García-Esquinas E, Pérez-Gómez B, Altzibar JM, Gracia-Lavedan E, Ederra M, Molina de la Torre AJ, LLorca FJ, Tardón A, Moreno V, Bayo J, Salas-Trejo D, Marcos-Gragera R, Pumarega J, Dierssen-Sotos T, Lera JP, de Miguel Medina MA, Tusquets I, Amiano P, Boldo E, Kogevinas M, Aragonés N, Castaño-Vinyals G, Pollán M. Cancer Epidemiol. 2016 Feb;40():22-30. doi: 10.1016/j.canep.2015.11.004. Epub: 2015 Nov 21. PMID: 26613540
  20. Association of diabetes and diabetes treatment with incidence of breast cancer.
    García-Esquinas E, Guinó E, Castaño-Vinyals G, Pérez-Gómez B, Llorca J, Altzibar JM, Peiró-Pérez R, Martín V, Moreno-Iribas C, Tardón A, Caballero FJ, Puig-Vives M, Guevara M, Villa TF, Salas D, Amiano P, Dierssen-Sotos T, Pastor-Barriuso R, Sala M, Kogevinas M, Aragonés N, Moreno V, Pollán M. Acta Diabetol. 2016 Feb;53(1):99-107. doi: 10.1007/s00592-015-0756-6. Epub: 2015 Apr 29. PMID: 25916213; PMCID: PMC4749645
  21. Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).
    Binefa G, Garcia M, Milà N, Fernández E, Rodríguez-Moranta F, Gonzalo N, Benito L, Clopés A, Guardiola J, Moreno V. Sci Rep. 2016 Jan 20;6():19532. doi: 10.1038/srep19532. Epub: 2016 Jan 20. PMID: 26787510; PMCID: PMC4726304